香港六宝典-免费公开资料大全

1999

LifeTech Scientific Corporation was established in Shenzhen, China

2001

HeartR™ PDA Occluder was approved by NMPA in China, becoming the first product successfully marketed by the company

2003

HeartR™ ASD Occluder was approved by NMPA in China

2004

Ankura™ TAA\AAA Stent Graft System and HeartR™ VSD Occluder were approved by NMPA in China

2005

Aegisy™ Vena Cava Filter was approved by NMPA in China

2006

SteerEase™ Introducer was approved by NMPA in China

2008

The company was accredited as a national high-tech enterprise in China

The company expanded its business into India market and incorporated Lifetech Scientific India Private Limited into the LifeTech family

2009

Aegisy™ Vena Cava Filter obtained the CE mark in EU, becoming the first product of the company to receive one

Cera™ Occluder series and SteerEase™ Introducer obtained the CE mark in EU

2010

SeQure™ Snare System received FDA approval in the United States, becoming the first product of the company to receive one

Fustar™ Steerable Introducer, Cera™ Vascular Plug System, Acumark™ Sizing Balloon, Cera™ Multi-Fenestrated ASD Occluder and SeQure™ Snare System obtained the CE mark in EU

2011

LifeTech Scientific Corporation was listed on the Hong Kong Stock Exchange (Stock Code: 1302.HK)

The company incorporated LifeTech Scientific (Europe) Coöperatief U.A. to further explore the European market

Fustar™ Steerable Introducer received FDA approval in the United States

CeraFlex™ Occluder series and Vascular Plugs, Ankura™ Stent Graft System obtained the CE mark in EU

2012

The company incorporated LifeTech Scientific (Netherlands) B.V. into the LifeTech family

Cera™ PDA Occluder and ASD Occluder were approved by NMPA in China

HeartR™ Occluder series, Cera™/CeraFlex™/IrisFit™ PFO Occluders and LawMax™ Dilator obtained the CE mark in EU

2013

Cera™ VSD Occluder was approved by NMPA in China

LawMax™ Dilator received FDA approval in the United States

2014

Fustar™ Steerable Introducer was approved by NMPA in China

2015

The company has been included in the Hang Seng Index

The company incorporated Lifetech Scientific America Corporation to add to its list of international subsidiaries

2016

The company has been included in the Shenzhen-Hong Kong Stock Connect Programs

The company established a subsidary in Hong Kong and Greece, respectively

LAmbre™ LAA Closure System and GoldenFlow™ Peripheral Bare Stent System obtained the CE mark in EU

SteerNavi™ Introducer was approved by NMPA in China

2017

LAmbre™ LAA Closure System, HeartTone™ Implantable Cardiac Pacemakers, SeQure™ Snare System, LawMax™ Dilator and Ankura™ II Stent Graft System were approved by NMPA in China

2018

The company established a strategic partnership with Ally Bridge Group, a global life science-focused investment firm

KONAR-MF™ VSD Occluder obtained the CE mark in EU

2019

The company incorporated LifeTech Scientific Deutschland GmbH to further expand its business in the heart of Europe

LAmbre™ LAA Closure System obtained FDA approval for the pre-market clinical study in the United States

Aelark™ Vena Cava Filter System was approved by NMPA in China

2020

LAmbre™ LAA Closure System obtained FDA approval for an investigator-initiated pre-market clinical trial in the United States

HeartR™ II ASD Occluder, Fustar™ mini Steerable Catheter, FiQure™ Vena Cava Filter Retrieval System, ZoeTrack™ Guidewire, FemCross™ 18 Peripheral Balloon Dilatation Catheter, Futhrough™ Stent Graft Balloon Catheter were approved by NMPA in China

Futhrough™ Endovascular Needle System obtained the CE mark in EU

2021

The invention patent “LAA Occluder” won the WIPO-CNIPA Award for Chinese Outstanding Patented Invention

G-iliac™ Iliac Artery Bifurcation Stent Graft System, Yuranos™ Abdominal Aortic Stent Graft System, LAxible™ LAA Occluder, LAnavi™ Jointed Steerable Introducer, OKcurve™ Steerable Delivery System, Freepath™ Guidance System and iCable™ Delivery Cable were approved by NMPA in China

IBS Angel™ Iron Bioresorbable Scaffold System obtained registration approval from Malaysian Medical Device Authority (MDA)

Xuper™ Open Surgery Stent Graft System obtained the CE mark in EU

2022

An FDA-approved investigator-initiated pre-market clinical trial of LAmbre™ Plus LAA Closure System obtained medical insurance coverage in the United States

Fitaya™ Vena Cava Filter System, FemCross™ 35 Peripheral Balloon Dilatation Catheter and Ankura™ llc Stent Graft System were approved by NMPA in China

2023

IBS Angel™ Iron Bioresorbable Scaffold System obtained CE MDR certification in EU

Peripheral Thrombus Aspiration Catheter, AcuMark™ Sizing Balloon and Epione® Surgical Navigation System were approved by NMPA in China

About Us